Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UFM1 pseudogene 1 (UFM1P1) is a non-coding genomic sequence classified as a pseudogene. It shares sequence similarity to the functional UFM1 gene, a member of the ubiquitin-like protein family involved in post-translational modification of proteins (ufmylation), but UFM1P1 does not encode an active protein and is not known to have biological function or therapeutic relevance. Pseudogenes such as UFM1P1 are generally remnants of once-functional genes now rendered inactive due to mutations or deletions; they do not generally serve as drug targets nor participate in recognized cellular pathways, disease mechanisms, or biomarker roles. The term “UFM1P1” refers specifically to a pseudogene, not the protein-coding or therapeutic target. For drug target research, information should be gathered about the functional gene Ubiquitin fold modifier 1 (UFM1), not UFM1P1; searching for UFM1P1 in disease-modifying or biomarker contexts will yield no actionable results.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UFM1 pseudogene 1 (UFM1P1).